Literature DB >> 24106878

Design of metastable β-sheet oligomers from natively unstructured peptide.

Marcos J Guerrero-Muñoz1, Diana L Castillo-Carranza, Urmi Sengupta, Mark A White, Rakez Kayed.   

Abstract

Amyloid oligomers represent the primary pathological species for neurodegenerative diseases such as Alzheimer's and Parkinson's diseases. Toxic oligomers are formed by many different proteins and peptides, but their polydispersity makes them highly dynamic and heterogeneous. One way to stabilize these structures is to prepare constrained peptides that can be used to study amyloid intermediates, to identify oligomer-specific drugs, and to generate conformational antibodies. These conformational antibodies have demonstrated that oligomers share a common epitope. In this research, we used a 40-amino acid unstructured segment of prion protein (Prp) 109-148 with substitutions of methionine for glycine (Prp-G) residues to prepare a stable and homogeneous population of β-sheet oligomer mimics. These structures were characterized by multiple biophysical and biochemical techniques that show characteristic features of oligomers. Finally, this preparation was not detected by three different sequence dependent prion antibodies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24106878      PMCID: PMC3867962          DOI: 10.1021/cn4001395

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  31 in total

1.  Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.

Authors:  C A McLean; R A Cherny; F W Fraser; S J Fuller; M J Smith; K Beyreuther; A I Bush; C L Masters
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

Review 2.  Amyloidogenic protein-membrane interactions: mechanistic insight from model systems.

Authors:  Sara M Butterfield; Hilal A Lashuel
Journal:  Angew Chem Int Ed Engl       Date:  2010-08-02       Impact factor: 15.336

3.  The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation.

Authors:  Eric M Norstrom; James A Mastrianni
Journal:  J Biol Chem       Date:  2005-05-25       Impact factor: 5.157

4.  CSSP2: an improved method for predicting contact-dependent secondary structure propensity.

Authors:  Sukjoon Yoon; William J Welsh; Heeyoung Jung; Young Do Yoo
Journal:  Comput Biol Chem       Date:  2007-06-16       Impact factor: 2.877

5.  Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation.

Authors:  Jessica W Wu; Leonid Breydo; J Mario Isas; Jerome Lee; Yurii G Kuznetsov; Ralf Langen; Charles Glabe
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

6.  Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.

Authors:  L F Lue; Y M Kuo; A E Roher; L Brachova; Y Shen; L Sue; T Beach; J H Kurth; R E Rydel; J Rogers
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

7.  Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice.

Authors:  Lauren M Billings; Salvatore Oddo; Kim N Green; James L McGaugh; Frank M LaFerla
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

8.  Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro.

Authors:  F Tagliavini; F Prelli; L Verga; G Giaccone; R Sarma; P Gorevic; B Ghetti; F Passerini; E Ghibaudi; G Forloni
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

9.  The deletion of amino acids 114-121 in the TM1 domain of mouse prion protein stabilizes its conformation but does not affect the overall structure.

Authors:  Bastian Thaa; Ralph Zahn; Ulrich Matthey; Peter M H Kroneck; Alexander Bürkle; Günter Fritz
Journal:  Biochim Biophys Acta       Date:  2007-11-29

Review 10.  Extrinsic fluorescent dyes as tools for protein characterization.

Authors:  Andrea Hawe; Marc Sutter; Wim Jiskoot
Journal:  Pharm Res       Date:  2008-01-03       Impact factor: 4.200

View more
  6 in total

1.  Digested disorder, Quarterly intrinsic disorder digest (October-November-December, 2013).

Authors:  Shelly DeForte; Krishna D Reddy; Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2015-03-09

Review 2.  Clinically oriented Alzheimer's biosensors: expanding the horizons towards point-of-care diagnostics and beyond.

Authors:  Bayu Tri Murti; Athika Darumas Putri; Yi-June Huang; Shih-Min Wei; Chih-Wei Peng; Po-Kang Yang
Journal:  RSC Adv       Date:  2021-06-08       Impact factor: 4.036

3.  High-resolution NMR characterization of low abundance oligomers of amyloid-β without purification.

Authors:  Samuel A Kotler; Jeffrey R Brender; Subramanian Vivekanandan; Yuta Suzuki; Kazutoshi Yamamoto; Martine Monette; Janarthanan Krishnamoorthy; Patrick Walsh; Meagan Cauble; Mark M Banaszak Holl; E Neil G Marsh; Ayyalusamy Ramamoorthy
Journal:  Sci Rep       Date:  2015-07-03       Impact factor: 4.379

4.  Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein.

Authors:  Urmi Sengupta; Nicha Puangmalai; Nemil Bhatt; Stephanie Garcia; Yingxin Zhao; Rakez Kayed
Journal:  Mol Neurobiol       Date:  2020-04-29       Impact factor: 5.590

5.  Mitochondrial ubiquitin ligase alleviates Alzheimer's disease pathology via blocking the toxic amyloid-β oligomer generation.

Authors:  Keisuke Takeda; Aoi Uda; Mikihiro Mitsubori; Shun Nagashima; Hiroko Iwasaki; Naoki Ito; Isshin Shiiba; Satoshi Ishido; Masaaki Matsuoka; Ryoko Inatome; Shigeru Yanagi
Journal:  Commun Biol       Date:  2021-02-12

Review 6.  The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy.

Authors:  Urmi Sengupta; Ashley N Nilson; Rakez Kayed
Journal:  EBioMedicine       Date:  2016-04-05       Impact factor: 8.143

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.